Bioengineering & Translational Medicine · 2018 · 106 citations · 37 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunoregulationImmunotherapyCancer ImmunotherapyCell-mediated ImmunityChimeric Antigen Receptor T-cell TherapyEffector T Cell FunctionRegulatory T CellsT Cell BiologyAdoptive Cell Therapy ImmunologyAdoptive T Cell Therapy CombinationsChimeric Antigen Receptor T Cell Combination TherapyImmunosuppressive FunctionT-cell ManufacturingTransforming Growth Factor Beta ReceptorsTransforming Growth Factor Beta-mediated Immune SuppressionTransforming Growth Factor-beta Signaling
A chimeric antigen receptor (CAR) that responds to transforming growth factor beta (TGF-β) enables the engineering of T cells that convert this immunosuppressive cytokine into a potent T-cell stimulant. However, clinical translation of TGF-β CAR-T cells for cancer therapy requires the ability to productively combine TGF-β responsiveness with tumor-targeting specificity. Furthermore, the potential concern that contaminating, TGF-β?producing regulatory T (Treg) cells may preferentially expand during TGF-β CAR-T cell manufacturing and suppress effector T (Teff) cells demands careful evaluation. Here, we demonstrate that TGF-β CAR-T cells significantly improve the anti-tumor efficacy of neighboring cytotoxic T cells. Furthermore, the introduction of TGF-β CARs into mixed T-cell populations does not result in the preferential expansion of Treg cells, nor do TGF-β CAR-Treg cells cause CAR-mediated suppression of Teff cells. These results support the utility of incorporating TGF-β CARs in the development of adoptive T-cell therapy for cancer.
37
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin et al. · New England Journal of Medicine · 2016 · 3.2K citations · Full text
Medicine, Immunology, Oncology +17
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text
Medicine, Immunology, Oncology +17